Biocompatibles UK Ltd
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$3.4M
Doctors Paid
33
Transactions
412
2019 Total
$447,641
Payment Breakdown by Category
Research$2.9M (85.4%)
Consulting$392,782 (11.6%)
Travel$69,615 (2.1%)
Food & Beverage$318.42 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.9M | 295 | 85.4% |
| Consulting Fee | $392,782 | 54 | 11.6% |
| Travel and Lodging | $69,615 | 51 | 2.1% |
| Space rental or facility fees (teaching hospital only) | $14,000 | 2 | 0.4% |
| Education | $10,000 | 1 | 0.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,500 | 3 | 0.3% |
| Food and Beverage | $318.42 | 6 | 0.0% |
Payments by Type
Research
$2.9M
295 transactions
General
$496,215
117 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| QYF0001 TS 102 EPOCH | $1.1M | 0 | 158 |
| Prostatic Artery Embolization PAE for Treatment for Signs & Symptoms of Benign Prostatic Hyperplasia BPH | $354,802 | 0 | 4 |
| Impact of Y-90 Radiation Segementectomy on HCC & Cirrhosis | $211,248 | 0 | 2 |
| QYF0002 TS 103 STOP-HCC | $185,108 | 0 | 49 |
| READY | $148,346 | 0 | 18 |
| Y-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia | $141,344 | 0 | 1 |
| TARGET Study | $112,599 | 0 | 16 |
| Assess Effect of Y90 therapy on Non-TargetBackground Liver | $104,489 | 0 | 5 |
| LEGACY Study | $86,427 | 0 | 8 |
| Effect of Polidocanol Endovenous Microfoam PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers VLUs | $72,792 | 0 | 1 |
| QYF0004 TS 104 YES-P | $60,473 | 0 | 3 |
| READY - BTG-007509-01 | $53,892 | 0 | 7 |
| Irinotecan-Eluting LC Bead-M1 DEBIRI-M1 for Patients with Liver Metastases | $50,000 | 0 | 1 |
| Doxorubicin-Eluting LC Bead M1 for Patients with HCC | $50,000 | 0 | 1 |
| Biomarker Analyses in HCC Patients Treated wTheraSphere | $42,721 | 0 | 1 |
| Safety & Efficacy of LC Bead Lumi for Prostatic Artery Embolization PAE | $27,241 | 0 | 4 |
| Chemoembolization wDoxorubicin-Eluting Microspheres for Liver Transplantation Candidates wHCC & Marginal Hepatic Reserve | $24,816 | 0 | 1 |
| Intravital Imaging of Embolization using Drug-Eluting Beads & Glass Microspheres in Animal Model of HCC | $24,286 | 0 | 2 |
| Retrospective Analysis of Safety & Efficacy DEBDOX M1 in HCC & DEBIRI M1 in mCRC | $18,702 | 0 | 1 |
| VIEW-VLU | $13,425 | 0 | 1 |
| LUMI PPE - BTG-13002-01 | $7,500 | 0 | 3 |
| Phase II LC Bead LUMI Radio-Opaque Embolic Beads to Detect & Characterize Vascularity of Hepatic Tumors during Treatment with Transarterial Embolization Alone or combined with Thermal Ablation | $7,000 | 0 | 2 |
| Prognosis of Liver Transplant Patients Undergoing Regional Therapy for HCC | $5,000 | 0 | 1 |
| LUMI PPE - BTG-13002-02 | $975.00 | 0 | 1 |
| LUMI PPE - BTG-13002-05 | $512.50 | 0 | 2 |
| LUMI PPE - BTG-13002-11 | $500.00 | 0 | 1 |
| LUMI PPE - BTG-13002-03 | $250.00 | 0 | 1 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Vascular & Interventional Radiology | $296,486 | 15 | $19,766 |
| Diagnostic Radiology | $127,111 | 8 | $15,889 |
| Specialist | $29,714 | 3 | $9,905 |
| Vascular Surgery | $10,000 | 1 | $10,000 |
| Internal Medicine | $7,594 | 2 | $3,797 |
| Transplant Surgery | $4,948 | 1 | $4,948 |
| Diagnostic Ultrasound | $3,774 | 1 | $3,774 |
| Neurological Surgery | $2,400 | 1 | $2,400 |
| Surgery | $188.00 | 1 | $188.00 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2017 |
|---|---|---|---|---|
| Dr. Govindarajan Narayanan, Md, MD | Vascular & Interventional Radiology | Miami, FL | $101,613 | $0 |
| Dr. Sean Tutton, Md, MD | Vascular & Interventional Radiology | San Diego, CA | $96,605 | $0 |
| Charles Nutting, Do, DO | Diagnostic Radiology | Greenwood Village, CO | $54,368 | $0 |
| Dr. Bulent Arslan, M.d, M.D | Vascular & Interventional Radiology | Chicago, IL | $40,425 | $0 |
| Dr. Dominic Yee, M.d, M.D | Diagnostic Radiology | Englewood, CO | $31,139 | $0 |
| Edward Kim, Md, MD | Specialist | New York, NY | $23,405 | $0 |
| Dr. Karun Sharma, M.d., Phd, M.D., PHD | Diagnostic Radiology | Washington, DC | $15,900 | $0 |
| Robert Suh, Md, MD | Vascular & Interventional Radiology | Los Angeles, CA | $15,644 | $0 |
| Dr. Antonios Gasparis, M.d, M.D | Vascular Surgery | Huntington, NY | $10,000 | $0 |
| Riccardo Lencioni, Md, MD | Diagnostic Radiology | Miami, FL | $9,600 | $0 |
| Dr. Siddharth Padia, M.d, M.D | Vascular & Interventional Radiology | Los Angeles, CA | $9,310 | $0 |
| Dr. Ryan Hickey, Md, MD | Vascular & Interventional Radiology | New York, NY | $7,621 | $0 |
| Guy Johnson | Diagnostic Radiology | Seattle, WA | $6,485 | $0 |
| Joshua Kuban, Md, Mms, MD, MMS | Diagnostic Radiology | Houston, TX | $6,409 | $0 |
| Armeen Mahvash, Md, MD | Vascular & Interventional Radiology | Houston, TX | $6,083 | $0 |
| Mahmood Razavi, M.d, M.D | Vascular & Interventional Radiology | Orange, CA | $5,217 | $0 |
| Raghu Kolluri, M.d, M.D | Specialist | Columbus, OH | $5,178 | $0 |
| Marcelo Facciuto, M.d, M.D | Transplant Surgery | New York, NY | $4,948 | $0 |
| Dr. Ripal Gandhi, M.d, M.D | Vascular & Interventional Radiology | Miami, FL | $4,205 | $0 |
| Dr. Eric Wehrenberg-Klee, M.d, M.D | Internal Medicine | Boston, MA | $4,061 | $0 |
| Matthew Callstrom, M.d, M.D | Diagnostic Ultrasound | Rochester, MN | $3,774 | $0 |
| Paul Oberstein, Md, MD | Internal Medicine | New York, NY | $3,533 | $0 |
| Dr. Jack Jennings, Md, MD | Diagnostic Radiology | Saint Louis, MO | $3,085 | $0 |
| Keith Sterling, M.d, M.D | Vascular & Interventional Radiology | Springfield, VA | $2,841 | $0 |
| Dr. William Rilling, Md, MD | Vascular & Interventional Radiology | Milwaukee, WI | $2,500 | $0 |
Ad
Top Products
- THERASPHERE - BIO $2.4M
- LC BEAD $567,989
Associated Products (3)
- LC BEAD $1.3M
- BEADBLOCK USA $216,217
- LC BEAD LUMI $40,311
Payment Categories
- Food & Beverage $318.42
- Consulting $392,782
- Travel & Lodging $69,615
- Research $2.9M
About Biocompatibles UK Ltd
Biocompatibles UK Ltd has made $3.4M in payments to 33 healthcare providers, recorded across 412 transactions in the CMS Open Payments database. In 2019, the company paid $447,641. The top product by payment volume is THERASPHERE - BIO ($2.4M).
Payments were distributed across 9 medical specialties. The top specialty by payment amount is Vascular & Interventional Radiology ($296,486 to 15 doctors).
Payment categories include: Food & Beverage ($318.42), Consulting ($392,782), Research ($2.9M), Travel & Lodging ($69,615).
Biocompatibles UK Ltd is associated with 3 products in the CMS Open Payments database.